Comments
Loading...

Biomarin Pharmaceutical

BMRNNASDAQ
Logo brought to you by Benzinga Data
$71.41
0.270.38%
At Close: -
$71.41
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
50%
Overview Rating
Speculative
Technicals Analysis
66
0100
Financials Analysis
40
0100

Biomarin Pharmaceutical (NASDAQ:BMRN) Stock Quotes, Forecast and News Summary

Biomarin Pharmaceutical Stock (NASDAQ: BMRN) stock price, news, charts, stock research, profile.

Open$71.75
Close$71.41
Volume / Avg.2.93M / 2.22M
Day Range$70.42 - $72.07
52 Wk Range68.83 - 99.56
Market Cap$13.60B
P/E Ratio53.89
Dividend Yield-
ExchangeNASDAQ
RSI
23
Short Interest
3.09%
Days to Cover4.1
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Jun
1
Jul
5
Aug
5
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Biomarin Pharmaceutical Inc.
Sector
Health Care
Industry
Biotechnology
BioMarin's focus is on rare-disease therapies. Genzyme markets Aldurazyme through its joint venture ...
Show More

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
BMRN
LEGN

FAQ

Q

How do I buy Biomarin Pharmaceutical (BMRN) stock?

A

You can purchase shares of Biomarin Pharmaceutical (NASDAQ:BMRN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Biomarin Pharmaceutical (BMRN) competitors?

Q

What is the forecast, or price target, for Biomarin Pharmaceutical (BMRN) stock?

A

Biomarin Pharmaceutical has a consensus price target of $104.08.

Q

What is the current price for Biomarin Pharmaceutical (BMRN)?

A

The stock price for Biomarin Pharmaceutical (NASDAQ: BMRN) is $71.41 last updated September 19, 2024 at 4:00 PM EDT.

Q

Does Biomarin Pharmaceutical (BMRN) pay a dividend?

A

There are no upcoming dividends for Biomarin Pharmaceutical.

Q

When is Biomarin Pharmaceutical (NASDAQ:BMRN) reporting earnings?

A

Biomarin Pharmaceutical’s Q3 earnings are confirmed for Wednesday, October 30, 2024.

Q

Is Biomarin Pharmaceutical (BMRN) going to split?

A

There is no upcoming split for Biomarin Pharmaceutical.

Q

What sector and industry does Biomarin Pharmaceutical (BMRN) operate in?

A

Biomarin Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch